Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vitaly S. Dubov"'
Autor:
Olga A. Aleshina, Kristina Zakurdaeva, Anastasia N. Vasileva, Sergey K. Dubov, Vitaly S. Dubov, Vladimir I. Vorobyev, Lev S. Butaev, Alena M. Sukhareva, Lubov V. Gavrilova, Inessa Yu. Toropova, Marina O. Popova, Aleksandr A. Siniaev, Aleksandr D. Kulagin, Kamil D. Kaplanov, Andrei A. Petrenko, Oksana I. Ochirova, Alina Karpova, Ekaterina Yu. Chelysheva, Anna G. Turkina, Margarita A. Gurianova, Liubov S. Al-Radi, Elena A. Gilyazitdinova, Elena K. Egorova, Yulia A. Chabaeva, Sergey M. Kulikov, Yulia V. Sveshnikova, Mikhail A. Kunst, Vasily Shuvaev, Anzhelika F. Rakhmani, Olga L. Panteleeva, Maria E. Grishunina, Olga S. Samoylova, Ekaterina Vorontsova, Daria V. Baryshnikova, Elena N. Parovichnikova
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aeed11ea33a0b517984c8fbcb6a2dfc0
https://doi.org/10.1016/j.clml.2023.04.002
https://doi.org/10.1016/j.clml.2023.04.002
Autor:
Vitaly S. Dubov, Vera Nevzorova, N. G. Plekhova, Alexandra V. Lagureva, Mikhail A. Tsygankov, Ksenia K. Maslennikova, Larisa V. Rodionova
Publikováno v:
The Bulletin of Contemporary Clinical Medicine. 12:44-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08a8876f56b348ea4dea18a78dc2aa0b
https://doi.org/10.20969/vskm.2019.12(4).44-51
https://doi.org/10.20969/vskm.2019.12(4).44-51
Publikováno v:
The Bulletin of Contemporary Clinical Medicine. 12:67-72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc2798ff9482add027a1e0e807cd3edf
https://doi.org/10.20969/vskm.2019.12(3).67-72
https://doi.org/10.20969/vskm.2019.12(3).67-72
Autor:
Inessa Yu. Toropova, Tatiana V. Gaponova, Valery G. Savchenko, Andrei Petrenko, M. Popova, Yulia Sveshnikova, Maria Grishunina, Alina Karpova, Kaplanov Kd, Alena Sukhareva, Anastasia N. Vasileva, Lev S. Butaev, Vera V. Troitskaya, Dasha Baryshnikova, Vitaly S. Dubov, Ekaterina Chelysheva, Kristina Zakurdaeva, Vasily Shuvaev, Oksana Ochirova, Julia Chabaeva, Vladimir I. Vorobyev, Sergei Dubov, Lubov Gavrilova, Olga A. Gavrilina, Aleksander A. Siniaev
Publikováno v:
Blood
Background: Research on the impact of COVID-19 on different patient populations has been of great value for the optimization of patient care since the start of the SARS-CoV-2 pandemic. Earlier, we reported the interim analysis of the immediate outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0eb5ea718b51b4c77b1c0ec920d52b2
http://europepmc.org/articles/PMC8701609
http://europepmc.org/articles/PMC8701609
Autor:
Sergey Dubov, Valery G. Savchenko, Lev S. Butaev, Hunan Julhakyan, Yulia Sveshnikova, Inessa Yu. Toropova, Oksana Ochirova, Olga A. Gavrilina, E A Gilyazitdinova, Aleksandr A. Siniaev, Vasily Shuvaev, Anastasia N. Vasileva, Lubov Gavrilova, Maria Grishunina, Kristina Zakurdaeva, Mikhail A. Kunst, Marina O. Popova, Vladimir I. Vorobyev, K D Kaplanov, Al'-Radi Ls, Andrei Petrenko, Yulia A. Chabaeva, Daria Baryshnikova, Vitaly S. Dubov
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia
Background Patients (pts) with lymphoproliferative diseases (LPD) are at high risk of COVID-19 severe and lethal course. Objective To evaluate treatment outcomes and risk factors in pts with LPD and COVID-19 in a real-world setting. Methods CHRONOS19
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac386586f20ac7457204c2d72791da1
http://europepmc.org/articles/PMC8404062
http://europepmc.org/articles/PMC8404062
Autor:
Oksana Ochirova, Olga A. Gavrilina, Aleksandr A. Siniaev, Anastasia N. Vasileva, Yulia Sveshnikova, Sergei Dubov, Yulia A. Chabaeva, Marina O. Popova, Lev S. Butaev, Kaplanov Kd, Anzhelika F. Rakhmani, Inessa Yu. Toropova, Vitaly S. Dubov, Lubov Gavrilova, Mikhail A. Kunst, Alena Sukhareva, Valery G. Savchenko, Andrei Petrenko, Ekaterina Chelysheva, Kristina Zakurdaeva
Publikováno v:
Journal of Clinical Oncology. 39:e18715-e18715
e18715 Background: Pts with hem diseases are at high risk of COVID-19 severe course and mortality. Emerging data on risk factors and outcomes in this patient population is of great value for developing strategies of medical care. Methods: CHRONOS19 i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::854a5d881e14c33970ac5bd8c79d4382
https://doi.org/10.1200/jco.2021.39.15_suppl.e18715
https://doi.org/10.1200/jco.2021.39.15_suppl.e18715
Autor:
Aleshina, Olga A., Zakurdaeva, Kristina, Vasileva, Anastasia N., Dubov, Sergey K., Dubov, Vitaly S., Vorobyev, Vladimir I., Butaev, Lev S., Sukhareva, Alena M., Gavrilova, Lubov V., Toropova, Inessa Yu., Popova, Marina O., Siniaev, Aleksandr A., Kulagin, Aleksandr D., Kaplanov, Kamil D., Petrenko, Andrei A., Ochirova, Oksana I., Karpova, Alina, Chelysheva, Ekaterina Yu., Turkina, Anna G., Gurianova, Margarita A.
Publikováno v:
Clinical Lymphoma, Myeloma & Leukemia; Aug2023, Vol. 23 Issue 8, p589-598, 10p